✦ LIBER ✦

Pemetrexed/bevacizumab maintenance combination stalls lung cancer

✍ Scribed by Kerri Wachter

Book ID: 118628821
Publisher: Frontline Medical Communications, Inc.
Year: 2011
Tongue: English
Weight: 51 KB
Volume: 8
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(12)70152-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab combined with pemetrexed plu

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

✍ Santoro, Armando; Hillerdal, Gunnar N.; Hoeffken, Gert; Favaretto, Adolfo; Carri 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Phase 2 trial of maintenance bevacizumab

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer

✍ James P. Stevenson; Corey J. Langer; Robert A. Somer; Tracey L. Evans; Kumar Raj 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB

PointBreak: A Randomized Phase III Study

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB

Dose-escalation study of pemetrexed in c

Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer

✍ Okamoto, Isamu; Takeda, Koji; Daga, Haruko; Miyazaki, Masaki; Yonesaka, Kimio; K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Randomized Phase III Trial of Maintenanc

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

✍ Barlesi, F.; Scherpereel, A.; Rittmeyer, A.; Pazzola, A.; Ferrer Tur, N.; Kim, J 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 188 KB

Treatment Rationale and Study Design for

Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology

✍ Ralph G. Zinner; Scott B. Saxman; Guangbin Peng; Matthew J. Monberg; Waldo I. Or 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB